Philips today said it has launched its OmniWire solid core pressure wire for coronary artery interventional procedures.
The solid core construction allows physicians to easily maneuver the wire in a patient’s circulatory system to measure blood pressure in the vessel while guiding catheter and stent delivery. It also supports instant wave-free ratio (iFR) measurements and Philips’s IntraSight interventional applications platform, which registers iFR data onto an angiogram to precisely identify vessels that need treatment.
“I have been very impressed with the handling of OmniWire, the new solid core design performed beautifully, and I was able to navigate the difficult case easily,” Dr. Jasvindar Singh, director of the catheterization lab at Barnes Jewish Hospital and associate professor at Washington University in St. Louis, said in a news release. “We used iFR co-registration and found that the patient needed a stent. I was then able to perform the whole procedure working over OmniWire. This is truly an innovation in percutaneous coronary interventions.”
Philips’s new wire support iFR and fractional flow reserve measurements. With IntraSight, the OmniWire can help physicians identify precise locations causing ischemia, plan stent length and placement with a virtual stent and predict physiologic improvement, according to the company.
“With integration and co-registration on our IntraSight platform, measurement with iFR, and now enhanced wire performance thanks to OmniWire, we’re providing clinicians with an advanced solution at every step of the procedure,” Chris Landon, senior VP and general manager of image guided therapy devices, said. “Physicians can confidently use a functional guidance strategy across all their patients, including in complex and multi-vessel cases. Today’s announcement demonstrates how our unique portfolio of systems, smart devices, software and services combines to deliver advanced procedure-oriented solutions.”
OmniWire is available in the U.S. and Japan.